Twist Bioscience and Ono Pharmaceutical collaborate
Partnership will discover and develop novel antibodies for a range of autoimmune diseases
Read Moreby John Pinching | Sep 1, 2023 | News | 0
Partnership will discover and develop novel antibodies for a range of autoimmune diseases
Read Moreby John Pinching | Mar 23, 2023 | News | 0
The partnership will involve progressing macrophage-targeting antibody treatment for cancer
Read Moreby John Pinching | Dec 14, 2022 | News | 0
R&D partnership will identify and develop novel therapeutic targets for future therapies
Read Moreby Anna Smith | Jul 19, 2019 | News | 0
Encouraging early data have been seen with the studied combination, as in a Phase Ib investigator sponsored trial from Japan called REGONIVO
Read Moreby Selina McKee | Jan 23, 2017 | News | 0
Merck & Co has agreed to pay Bristol-Myers Squibb and Ono Pharmaceutical Co $625 million plus royalties to lay to rest a global patent battle relating to cancer immunotherapy Keytruda.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
